| 000 | 01195 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512012509.0 | ||
| 264 | 0 | _c19890626 | |
| 008 | 198906s 0 0 eng d | ||
| 022 | _a0197-4580 | ||
| 024 | 7 |
_a10.1016/0197-4580(89)90031-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMolloy, D W | |
| 245 | 0 | 0 |
_aAcute effects of oral pyridostigmine on memory and cognitive function in SDAT. _h[electronic resource] |
| 260 |
_bNeurobiology of aging _c |
||
| 300 |
_a199-204 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMemory _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPyridostigmine Bromide _xadministration & dosage |
| 700 | 1 | _aCape, R D | |
| 773 | 0 |
_tNeurobiology of aging _gvol. 10 _gno. 2 _gp. 199-204 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0197-4580(89)90031-6 _zAvailable from publisher's website |
| 999 |
_c2663361 _d2663361 |
||